Logo image of RCT.CA

ROCHESTER RESOURCES LTD (RCT.CA) Stock Fundamental Analysis

TSX-V:RCT - TSX Venture Exchange - CA77174P3007 - Common Stock - Currency: CAD

0.02  -0.01 (-20%)

Fundamental Rating

1

Overall RCT gets a fundamental rating of 1 out of 10. We evaluated RCT against 802 industry peers in the Metals & Mining industry. RCT may be in some trouble as it scores bad on both profitability and health. RCT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

RCT had negative earnings in the past year.
RCT had a negative operating cash flow in the past year.
RCT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years RCT had a positive operating cash flow.
RCT.CA Yearly Net Income VS EBIT VS OCF VS FCFRCT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

RCT's Return On Assets of -48.80% is on the low side compared to the rest of the industry. RCT is outperformed by 63.84% of its industry peers.
Industry RankSector Rank
ROA -48.8%
ROE N/A
ROIC N/A
ROA(3y)-77.49%
ROA(5y)-51.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCT.CA Yearly ROA, ROE, ROICRCT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

RCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCT.CA Yearly Profit, Operating, Gross MarginsRCT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

0

2. Health

2.1 Basic Checks

RCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RCT remains at a similar level compared to 1 year ago.
RCT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RCT has a worse debt to assets ratio.
RCT.CA Yearly Shares OutstandingRCT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
RCT.CA Yearly Total Debt VS Total AssetsRCT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -18.39, we must say that RCT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RCT (-18.39) is worse than 75.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.39
ROIC/WACCN/A
WACC4.12%
RCT.CA Yearly LT Debt VS Equity VS FCFRCT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

2.3 Liquidity

A Current Ratio of 0.24 indicates that RCT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.24, RCT is doing worse than 74.31% of the companies in the same industry.
A Quick Ratio of 0.20 indicates that RCT may have some problems paying its short term obligations.
RCT has a worse Quick ratio (0.20) than 75.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.2
RCT.CA Yearly Current Assets VS Current LiabilitesRCT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2

3. Growth

3.1 Past

RCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.19%, which is quite impressive.
Looking at the last year, RCT shows a decrease in Revenue. The Revenue has decreased by -1.40% in the last year.
The Revenue has been growing by 12.69% on average over the past years. This is quite good.
EPS 1Y (TTM)37.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.51%
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-0.83%
Revenue growth 5Y12.69%
Sales Q2Q%36.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCT.CA Yearly Revenue VS EstimatesRCT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCT.CA Price Earnings VS Forward Price EarningsRCT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCT.CA Per share dataRCT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RCT!.
Industry RankSector Rank
Dividend Yield N/A

ROCHESTER RESOURCES LTD

TSX-V:RCT (4/29/2025, 7:00:00 PM)

0.02

-0.01 (-20%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-26 2022-01-26
Inst Owners2.85%
Inst Owner ChangeN/A
Ins Owners59.75%
Ins Owner ChangeN/A
Market Cap942.80K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.28
BVpS-0.76
TBVpS-0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.49%
ROA(5y)-51.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 332.11%
Cap/Sales 12.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.2
Altman-Z -18.39
F-Score4
WACC4.12%
ROIC/WACCN/A
Cap/Depr(3y)98.13%
Cap/Depr(5y)156.65%
Cap/Sales(3y)4.04%
Cap/Sales(5y)4.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-0.83%
Revenue growth 5Y12.69%
Sales Q2Q%36.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1570.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-241.29%
OCF growth 3Y-27.62%
OCF growth 5YN/A